Ignite Creation Date:
2024-05-06 @ 12:35 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03793361
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2018-12-28
Brief Title:
Phase II Study of Regorafenib as Maintenance Therapy
Sponsor:
Centre Oscar Lambret
Organization:
Centre Oscar Lambret
Organization Data
Organization:
Centre Oscar Lambret
Class:
OTHER
Study ID:
EREMISS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Oscar Lambret
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None